96. Crohn disease Clinical trials / Disease details
Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00278577 (ClinicalTrials.gov) | April 2001 | 15/1/2006 | Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease | Immune Ablation and Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease | CROHN'S DISEASE | Biological: Immune Ablation and Hematopoietic Stem Cell Support | Richard Burt, MD | NULL | Terminated | N/A | 60 Years | Both | 25 | Phase 1 | United States |